Celsus Therapeutics Plc. CLTX
The big winner from yesterday’s report turned out to be CLTX. We tagged the stock after catching it on a routine news scan; the company announced an all-stock exchange agreement with Volution Immuno Pharmaceuticals in which CLTX will absorb the company as a wholly-owned subsidiary, and form a new company aimed at developing treatments for a range of rare and orphan autoimmune and inflammatory diseases >> READ PR
Back in February, a bleak annual report led CLTX to fall off of a cliff, tumbling from the $6+ range down to roughly a dollar. Over the next several months, the stock continued to trend downward, culminating in a 52-week low of .40 at the end of May. Since that time, it received a little boost, rising to the .60-range.
That’s where we came upon it yesterday, and it was fortunate that we began paying attention when we did. After dipping to a daily low of .5012, the stock ran into the close, reaching a high of .68; a solid 36% intraday move. The late boost of momentum is carrying over into the premarket today, with CLTX hitting an early high of .99. From our observed low yesterday, that’s a 98% swing.
We’ll look for it to continue to build its base with higher lows, and to potentially crack through resistance into dollar-territory.
Callaway Golf Co. ELY
ELY is contributing to the newsreel this morning, announcing the signing of a highly talented young golfer. Upon taking notice of this, we’ve also seen that ELY has been building a heck of a chart setup over the past few sessions.
The stock has registered higher lows for each of the last four consecutive trading sessions, and is exhibiting a great deal of promise with regard to a number of bullish signals on the chart that we’ve pointed out on the snapshot below. Between that, and it being the peak of golf season, we’ll be paying close attention to ELY.
CARLSBAD, Calif., July 14, 2015 /PRNewswire/ — Today Callaway Golf officially announced that it has reached a Staff Pro agreement with former college golf phenom, Julien Brun. A native of Anitbes, France, Brun turns pro after an unbelievable career at Texas Christian University (TCU), where he was a 3-time First Team All-American and a 3-time Academic All-American.>> FULL PR
EnteroMedics, Inc. ETRM
Speaking of ripening charts, we’ve got to tag ETRM this morning as a bottom-play that could be in line for a serious rebound. One look at the chart is all it takes to see what we mean.
We’ve got an egregiously oversold RSI, and the stock has fallen to new 52-week lows in the past couple of sessions. There are also a couple of gaps to fill from 44-.50 and from .83-.96 on a possible retrace, so we’ll be monitoring this play which we feel has breakout potential based on these factors.
BIOC, CLSN, TBIO, CEL, VLTC, CPXX